AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
COMPARISON OF 6 EXTRACTION TECHNIQUES FOR ISOLATION OF DNA FROM FILAMENTOUS FUNGI
Authors: VANBURIK JAH SCHRECKHISE RW WHITE TC BOWDEN RA MYERSON D
Citation: Jah. Vanburik et al., COMPARISON OF 6 EXTRACTION TECHNIQUES FOR ISOLATION OF DNA FROM FILAMENTOUS FUNGI, MEDICAL MYCOLOGY, 36(5), 1998, pp. 299-303
MULTIDIMENSIONAL FLOW-CYTOMETRY OF MARROW CAN DIFFERENTIATE LEUKEMIC FROM NORMAL LYMPHOBLASTS AND MYELOBLASTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION
Authors: WELLS DA SALE GE SHULMAN HM MYERSON D BRYANT EM GOOLEY T LOKEN MR
Citation: Da. Wells et al., MULTIDIMENSIONAL FLOW-CYTOMETRY OF MARROW CAN DIFFERENTIATE LEUKEMIC FROM NORMAL LYMPHOBLASTS AND MYELOBLASTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION, AJCP. American journal of clinical pathology, 110(1), 1998, pp. 84-94
HEPATITIS-C VIRUS (HCV) INFECTION AND BONE-MARROW TRANSPLANTATION (BMT) - A PROSPECTIVE-STUDY WITH 10-YEAR FOLLOW-UP
Authors: STRASSER SL SPURGEON CL KIM S SCHOCH HG MYERSON D SULLIVAN KM MCDONALD GB
Citation: Sl. Strasser et al., HEPATITIS-C VIRUS (HCV) INFECTION AND BONE-MARROW TRANSPLANTATION (BMT) - A PROSPECTIVE-STUDY WITH 10-YEAR FOLLOW-UP, Hepatology, 28(4), 1998, pp. 453-453
PANFUNGAL PCR ASSAY FOR DETECTION OF FUNGAL INFECTION IN HUMAN BLOOD SPECIMENS
Authors: VANBURIK JA MYERSON D SCHRECKHISE RW BOWDEN RA
Citation: Ja. Vanburik et al., PANFUNGAL PCR ASSAY FOR DETECTION OF FUNGAL INFECTION IN HUMAN BLOOD SPECIMENS, Journal of clinical microbiology, 36(5), 1998, pp. 1169-1175
THE EFFECT OF PROPHYLACTIC FLUCONAZOLE ON THE CLINICAL SPECTRUM OF FUNGAL DISEASES IN BONE-MARROW TRANSPLANT RECIPIENTS WITH SPECIAL ATTENTION TO HEPATIC CANDIDIASIS - AN AUTOPSY STUDY OF 355 PATIENTS
Authors: VANBURIK JAH LEISENRING W MYERSON D HACKMAN RC SHULMAN HM SALE GE BOWDEN RA MCDONALD GB
Citation: Jah. Vanburik et al., THE EFFECT OF PROPHYLACTIC FLUCONAZOLE ON THE CLINICAL SPECTRUM OF FUNGAL DISEASES IN BONE-MARROW TRANSPLANT RECIPIENTS WITH SPECIAL ATTENTION TO HEPATIC CANDIDIASIS - AN AUTOPSY STUDY OF 355 PATIENTS, Medicine, 77(4), 1998, pp. 246-254
CYTOMEGALOVIRUS DISEASE OCCURRING BEFORE ENGRAFTMENT IN MARROW TRANSPLANT RECIPIENTS
Authors: LIMAYE AP BOWDEN RA MYERSON D BOECKH M
Citation: Ap. Limaye et al., CYTOMEGALOVIRUS DISEASE OCCURRING BEFORE ENGRAFTMENT IN MARROW TRANSPLANT RECIPIENTS, Clinical infectious diseases, 24(5), 1997, pp. 830-835
ACUTE-PANCREATITIS IN MARROW TRANSPLANT PATIENTS - PREVALENCE AT AUTOPSY AND RISK FACTOR-ANALYSIS
Authors: KO CW GOOLEY T SCHOCH HG MYERSON D HACKMAN RC SHULMAN HM SALE GE LEE SP MCDONALD GB
Citation: Cw. Ko et al., ACUTE-PANCREATITIS IN MARROW TRANSPLANT PATIENTS - PREVALENCE AT AUTOPSY AND RISK FACTOR-ANALYSIS, Bone marrow transplantation, 20(12), 1997, pp. 1081-1086
PLASMA POLYMERASE CHAIN-REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION - COMPARISON WITH POLYMERASE CHAIN-REACTION USING PERIPHERAL-BLOOD LEUKOCYTES, PP65 ANTIGENEMIA, AND VIRAL CULTURE
Authors: BOECKH M GALLEZHAWKINS GM MYERSON D ZAIA JA BOWDEN RA
Citation: M. Boeckh et al., PLASMA POLYMERASE CHAIN-REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION - COMPARISON WITH POLYMERASE CHAIN-REACTION USING PERIPHERAL-BLOOD LEUKOCYTES, PP65 ANTIGENEMIA, AND VIRAL CULTURE, Transplantation, 64(1), 1997, pp. 108-113
IDIOPATHIC-PNEUMONIA-SYNDROME - CHANGING SPECTRUM OF LUNG INJURY AFTER MARROW TRANSPLANTATION
Authors: KANTROW SP HACKMAN RC BOECKH M MYERSON D CRAWFORD SW
Citation: Sp. Kantrow et al., IDIOPATHIC-PNEUMONIA-SYNDROME - CHANGING SPECTRUM OF LUNG INJURY AFTER MARROW TRANSPLANTATION, Transplantation, 63(8), 1997, pp. 1079-1086
CD8 AND Y-CHROMOSOME DOUBLE STAIN SHOWS EFFECTOR-CELLS IN GVHD ARE DONOR CYTOTOXIC T-LYMPHOCYTES
Authors: WILSON D MYERSON D BEAUCHAMP M SALE G
Citation: D. Wilson et al., CD8 AND Y-CHROMOSOME DOUBLE STAIN SHOWS EFFECTOR-CELLS IN GVHD ARE DONOR CYTOTOXIC T-LYMPHOCYTES, Laboratory investigation, 76(1), 1997, pp. 1092-1092
CIRCULATING CYTOMEGALOVIRUS(CMV)-INFECTED ENDOTHELIAL-CELLS IN MARROWTRANSPLANT PATIENTS WITH CMV DISEASE AND CMV INFECTION
Authors: SALZBERGER B MYERSON D BOECKH M
Citation: B. Salzberger et al., CIRCULATING CYTOMEGALOVIRUS(CMV)-INFECTED ENDOTHELIAL-CELLS IN MARROWTRANSPLANT PATIENTS WITH CMV DISEASE AND CMV INFECTION, The Journal of infectious diseases, 176(3), 1997, pp. 778-781
HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN ESOPHAGEAL CARCINOMAS FROM ALASKANATIVES
Authors: MILLER BA DAVIDSON M MYERSON D ICENOGLE J LANIER AP TAN J BECKMANN AM
Citation: Ba. Miller et al., HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN ESOPHAGEAL CARCINOMAS FROM ALASKANATIVES, International journal of cancer, 71(2), 1997, pp. 218-222
ASSOCIATION OF SPECIFIC CYTOMEGALOVIRUS GENOTYPES WITH DEATH FROM MYELOSUPPRESSION AFTER MARROW TRANSPLANTATION
Authors: TOROKSTORB B BOECKH M HOY C LEISENRING W MYERSON D GOOLEY T
Citation: B. Torokstorb et al., ASSOCIATION OF SPECIFIC CYTOMEGALOVIRUS GENOTYPES WITH DEATH FROM MYELOSUPPRESSION AFTER MARROW TRANSPLANTATION, Blood, 90(5), 1997, pp. 2097-2102
PREVALENCE OF HEPATITIS-G VIRUS IN PATIENTS WITH APLASTIC-ANEMIA
Authors: KIEM HP MYERSON D STORB R MCDONALD GB SPURGEON CL LEISENRING W
Citation: Hp. Kiem et al., PREVALENCE OF HEPATITIS-G VIRUS IN PATIENTS WITH APLASTIC-ANEMIA, Blood, 90(3), 1997, pp. 1335-1336
EVIDENCE FOR FETAL CELLS IN SKIN, KIDNEY AND BRONCHOALVEOLAR LAVAGE OF FEMALE SCLERODERMA PATIENTS
Authors: EVANS PC WILSON D MYERSON D FURST DE MALONEY S MOORE JM NELSON JL
Citation: Pc. Evans et al., EVIDENCE FOR FETAL CELLS IN SKIN, KIDNEY AND BRONCHOALVEOLAR LAVAGE OF FEMALE SCLERODERMA PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 1012-1012
RECOMBINANT HUMAN LIGAND FOR MPL, MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF), STIMULATES THROMBOPOIESIS IN-VIVO IN NORMAL AND MYELOSUPPRESSED BABOONS
Authors: ANDREWS RG WINKLER A MYERSON D BRIDDELL RA KNITTER GH MCNIECE IK HUNT P
Citation: Rg. Andrews et al., RECOMBINANT HUMAN LIGAND FOR MPL, MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF), STIMULATES THROMBOPOIESIS IN-VIVO IN NORMAL AND MYELOSUPPRESSED BABOONS, Stem cells, 14(6), 1996, pp. 661-677
PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN MARROW TRANSPLANT PATIENTS
Authors: SPURGEON CL MYERSON D KIEM HP MCDONALD GB
Citation: Cl. Spurgeon et al., PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN MARROW TRANSPLANT PATIENTS, Hepatology, 24(4), 1996, pp. 1158-1158
HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: DEMIRER T BUCKNER CD APPELBAUM FR CLIFT R STORB R MYERSON D LILLEBY K ROWLEY S BENSINGER WI
Citation: T. Demirer et al., HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Bone marrow transplantation, 17(5), 1996, pp. 769-774
HEPATITIS-C VIRUS (HCV) INFECTION IN BONE-MARROW TRANSPLANT PATIENTS AFTER TRANSFUSIONS FROM ANTI-HCV-POSITIVE BLOOD-DONORS
Authors: SHUHART MC MYERSON D SPURGEON CL BEVAN CA SAYERS MH MCDONALD GB
Citation: Mc. Shuhart et al., HEPATITIS-C VIRUS (HCV) INFECTION IN BONE-MARROW TRANSPLANT PATIENTS AFTER TRANSFUSIONS FROM ANTI-HCV-POSITIVE BLOOD-DONORS, Bone marrow transplantation, 17(4), 1996, pp. 601-606
PREVENTION OF TRANSMISSION OF HEPATITIS-G VIRUS IN BONE-MARROW TRANSPLANTATION BY TREATING THE DONOR WITH ALPHA-INTERFERON
Authors: VANCE EA SOIFFER RJ MCDONALD GB MYERSON D FINGEROTH J RITZ J
Citation: Ea. Vance et al., PREVENTION OF TRANSMISSION OF HEPATITIS-G VIRUS IN BONE-MARROW TRANSPLANTATION BY TREATING THE DONOR WITH ALPHA-INTERFERON, Transplantation, 62(9), 1996, pp. 1358-1360
MARROW ALLOGRAFT FAILURE IS ASSOCIATED WITH SPECIFIC CYTOMEGALOVIRUS (CMV) GENOTYPES
Authors: HOV C GOOLEY T LEISENRING W BOECKH M MYERSON D TOROKSTORB B
Citation: C. Hov et al., MARROW ALLOGRAFT FAILURE IS ASSOCIATED WITH SPECIFIC CYTOMEGALOVIRUS (CMV) GENOTYPES, Blood, 88(10), 1996, pp. 1193-1193
INCREASED RISK OF LATE CMV INFECTION AND DISEASE IN ALLOGENEIC MARROWTRANSPLANT RECIPIENTS AFTER GANCICLOVIR PROPHYLAXIS IS DUE TO A LACK OF CMV-SPECIFIC T-CELL RESPONSES
Authors: BOECKH M RIDDELL SR CUNNINGHAM T MYERSON D FLOWERS M BOWDEN RA
Citation: M. Boeckh et al., INCREASED RISK OF LATE CMV INFECTION AND DISEASE IN ALLOGENEIC MARROWTRANSPLANT RECIPIENTS AFTER GANCICLOVIR PROPHYLAXIS IS DUE TO A LACK OF CMV-SPECIFIC T-CELL RESPONSES, Blood, 88(10), 1996, pp. 1195-1195
PREVALENCE OF HEPATITIS-G VIRUS (AGV) IN 18 PATIENTS WITH HEPATITIS-ASSOCIATED APLASTIC-ANEMIA
Authors: KIEM HP SPURGEON CL MYERSON D STORB R MCDONALD GB
Citation: Hp. Kiem et al., PREVALENCE OF HEPATITIS-G VIRUS (AGV) IN 18 PATIENTS WITH HEPATITIS-ASSOCIATED APLASTIC-ANEMIA, Blood, 88(10), 1996, pp. 2100-2100
CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED EARLY TREATMENT WITH GANCICLOVIR VERSUS GANCICLOVIR AT ENGRAFTMENT AFTER ALLOGENEIC MARROW TRANSPLANTATION - A RANDOMIZED DOUBLE-BLIND-STUDY
Authors: BOECKH M GOOLEY TA MYERSON D CUNNINGHAM T SCHOCH G BOWDEN RA
Citation: M. Boeckh et al., CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED EARLY TREATMENT WITH GANCICLOVIR VERSUS GANCICLOVIR AT ENGRAFTMENT AFTER ALLOGENEIC MARROW TRANSPLANTATION - A RANDOMIZED DOUBLE-BLIND-STUDY, Blood, 88(10), 1996, pp. 4063-4071
FUNGAL LIVER INFECTION IN MARROW TRANSPLANT RECIPIENTS - PREVALENCE AT AUTOPSY, PREDISPOSING FACTORS, AND CLINICAL-FEATURES
Authors: ROSSETTI F BRAWNER DL BOWDEN R MEYER WG SCHOCH HG FISHER L MYERSON D HACKMAN RC SHULMAN HM SALE GE MEYERS JD MCDONALD GB
Citation: F. Rossetti et al., FUNGAL LIVER INFECTION IN MARROW TRANSPLANT RECIPIENTS - PREVALENCE AT AUTOPSY, PREDISPOSING FACTORS, AND CLINICAL-FEATURES, Clinical infectious diseases, 20(4), 1995, pp. 801-811
Risultati: 1-25 | 26-47